Compugen Ltd. (NASDAQ:CGEN) noted trading 1.87% off 52-week high price. On the other end, the stock has been noted 284.98% away from the low price over the last 52-weeks. The stock changed 7.46% to recent value of $10.51. The stock transacted 1812320 shares during most recent day however it has an average volume of 369.45K shares. The company has 67.39M of outstanding shares and 67.39M shares were floated in the market.
On Feb. 20, 2020, Compugen Ltd. (NASDAQ:CGEN) a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, disclosed financial results for the fourth quarter and full year ended December 31, 2019.
2019 was a transformative year for Compugen and we are incredibly proud of the progress we have made in advancing COM701 and COM902, said Anat Cohen-Dayag, Ph.D., President and CEO of Compugen. We are excited about our unique position in the immuno-oncology space as to our knowledge we are the only company with two clinical programs that address PVRIG and TIGIT, parallel inhibitory pathways of the DNAM axis. This differentiator is particularly important given the increasing excitement and growing recognition of the DNAM axis in cancer immunotherapy as evidenced by the development of other TIGIT antibodies in pharma. In addition, the encouraging initial signals of anti-tumor activity with COM701 monotherapy in an extremely challenging, refractory, all-comer population, has bolstered our conviction that targeting PVRIG as a newly discovered inhibitory pathway in the larger DNAM axis, has the potential to expand the reach of cancer immunotherapy. Its earnings per share (EPS) expected to touch remained 43.50% for this year.
According to the most recent quarter its current ratio was 7.2 that represents company’s ability to meet its current financial obligations. The price moved ahead of 31.15% from the mean of 20 days, 56.09% from mean of 50 days SMA and performed 123.29% from mean of 200 days price. Company’s performance for the week was 15.49%, 64.99% for month and YTD performance remained 76.34%.
Erik Brown is diligent and proactive when it comes to Finance news reporting. He has as a keen eye for technologies and has predicted quite a few successful startups over the last couple of years. Erik goal with this website is to report accurately on all kinds of stock news, and have a great deal of passion for Finance and active reporting. Erik is a journalism graduate with keen interest in covering Finance news – specifically startups.
Email: [email protected]
Address: 1202 Lewis Street, Sulphur, LA 70663, USA
Contact number: 337-513-4375